UBS Raises PT on Colfax (CFX), Sees Years of Strong Growth
Tweet
Share
E-mailGet Alerts CFX Hot Sheet
Price: $39.06 --0%
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 4
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 4
Join SI Premium – FREE
UBS boosted its price target on Buy-rated Colfax Corporation (NYSE: CFX) from $38 to $42 calling in a "compelling long-term growth story."
While the stock is not without risks, UBS views it as among the most attractive multi-year growth stories in the sector.
"We still expect a '12-'16 adj. EPS CAGR of 30%+ (albeit, off a lower '12 base), driven by deleveraging, restructuring cost saving initiatives, conversion of the convertible preferred, and (hopefully) a cyclical recovery. We also see upside from future M&A activity. However, given CFX's outperformance since July, and lower base-year EPS for ’12, CFX is now somewhat more of a "macro bet" than it was in late '11/1H12."
UBS Revised '12/'13 EPS estimates are $1.32/$2.05, respectively.
For an analyst ratings summary and ratings history on Colfax Corporation click here. For more ratings news on Colfax Corporation click here.
Shares of Colfax Corporation closed at $35.29 yesterday.
While the stock is not without risks, UBS views it as among the most attractive multi-year growth stories in the sector.
"We still expect a '12-'16 adj. EPS CAGR of 30%+ (albeit, off a lower '12 base), driven by deleveraging, restructuring cost saving initiatives, conversion of the convertible preferred, and (hopefully) a cyclical recovery. We also see upside from future M&A activity. However, given CFX's outperformance since July, and lower base-year EPS for ’12, CFX is now somewhat more of a "macro bet" than it was in late '11/1H12."
UBS Revised '12/'13 EPS estimates are $1.32/$2.05, respectively.
For an analyst ratings summary and ratings history on Colfax Corporation click here. For more ratings news on Colfax Corporation click here.
Shares of Colfax Corporation closed at $35.29 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades UDR, Inc. (UDR) to Buy
- Boston Scientific (BSX) PT Raised to $86 at Truist Securities
- Canadian Pacific Kansas City Limited (CP) PT Lowered to $82 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
